We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Providing dental professionals with an online Personal Development Plan for their Continuing Professional Development. Dentinal Tubules currently has more than 2,100 individuals registered to use the service and over 2,700 dental practice professionals that are paying for a subscription. Dentinal Tubules hosts more than 1,500 educational and certified videos to help with a professional's CPD, in addition they also offer live courses, a livestream and an annual congress. Investments will be used to enhance, develop and bring the technology in-house.
days to go: Expired investment: £155,820
Infections can be reduced and patient quality of life can be improved by using antimicrobial wound care materials developed by Pertinax. In vitro studies have already been performed using the company's development across multiple applications.
days to go: Expired investment: £616,916
Please watch the video for more information
days to go: Expired investment: £607,175
During their stay in hospital, around 7-10% of patients attract unexpected infections. In some cases, this is caused by unclean complex surgical tools. Aspetium have developed ultrasonic washers (dubbed "uSonic") to thoroughly decontaminate expensive surgical instruments, which can be safely reused to potentially prevent easily avoidable infections.
days to go: Expired investment: £151,167
Pioneering medical device company with patented technologies in the "key hole" surgery market 
days to go: Expired investment: £600,083
Please watch the video for more information
days to go: Expired investment: £257,501
Zero Carbon Farms (ZCF) is one of the first Controlled Environment Farms (CEF) that supplies blue-chip customers with local, nutritious and sustainable produce all year round. The company argues that its indoor farm has reduced growing days by up to 50% and increased average yields by 20% compared to conventional farming. ZCF asserts that it is carbon neutral, powered by 100% renewable energy, and is soon to acquire a 'B Corporation' certification in 2021. It aims to become a contender in the micro herbs and indoor salads market in the UK that is worth £624 million per annum. ZCF has supplied 274,863 units of fresh produce in 2019/2020 and is a supplier to Marks and Spencer, Whole Foods, Tesco, and Reynolds Catering Supplies. The company has also entered into R&D partnerships with Cambridge University, Nottingham Trent University, and Alan Turing Institute. It will use the investment to build a second farm on a new site, automate key processes, and invest in further yield-improving technologies.
days to go: Expired investment: £4,301,337
Qure’s aim is to provide individual healthcare that is both affordable and highly convenient, becoming the platform of choice for both patients and practitioners. Qure offer 24/7 private healthcare, without the huge price tag that is usually associated with these kinds of services. 
days to go: Expired investment: £1,162,206
OvuSense has been designed for women that struggle to conceive, actively predicting fertility patterns.  The OvuSense system has two parts a smartphone app and a medical grade vaginal sensor. OvuSense works for all women. The product gives a 24 hour prediction within your cycle.
days to go: Expired investment: £100,000
Belluscura aims at attending millions of people worldwide who are suffering from chronic lung diseases by providing them with the X-PLOR, portable, a lightweight, oxygen delivery device. It has developed it mainly to improve both the mobility and the life quality of the patients suffering from Chronic Obstructive Pulmonary Disease globally. It also has an exclusive license to a patented portable oxygen concentrator, the X-PLOR, that supplies 96% pure oxygen to patients 24/7. It's X-PLOR weights only 1.4kg and is 33% lighter, and provides 37% more oxygen per kg than its leading opponents. As smoke, pollution, and lives increase, the oxygen market will continue to grow from £1.1bn to £1.9bn by 2024. So, according to its market research, a 3% market share within 3 years could generate £46m in sales. With the funds raised, it is planning to extend its proprietary oxygen platform technology into other multi £bn markets such as wound care and sleep. Furthermore, it has filed patents on a next-generation portable artificial lung.
days to go: Expired investment: £543,670
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph